Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ken Wyman"'
Autor:
Omar Eton, David F. McDermott, Kathleen Sanders, Michael B. Atkins, Jeffrey A. Sosman, Christine Byrnes, Francie J. Hubbard, Ken Wyman, Victor G. Prieto
Publikováno v:
Cancer. 106(9)
BACKGROUND Systemic treatment of metastatic melanoma is largely ineffective and alternative approaches are needed. Imatinib mesylate is an oral tyrosine kinase inhibitor that targets bcr-Abl, c-kit, platelet-derived growth factor receptor (PDGFR)-α,
Autor:
Mace L. Rothenberg, Hak Choy, Bapsi Chakravarthy, Adrian Scott Pearson, Ken Wyman, Robert D. Beauchamp, Jordan Berlin, A. Craig Lockhart, Yu Shyr, Carol Caillouette, Nipun B. Merchant, Karen L. Tedesco
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 76(1)
Background and purpose In vitro studies have suggested that 9-nitro-20(s)-Camptothecin (9NC/Orathecin/Rubitecan) can enhance the effects of radiation. We conducted a phase I study to assess the toxicity and determine the maximum tolerated dose of 9NC
Autor:
Charles D. Blanke, Yu Shyr, Steve Leach, Bapsi Chakravarthy, John Roberts, Hak Choy, Jordan Berlin, Carol Caillouette, Karen L. Tedesco, Ming Teng, Ken Wyman, John L. Tarpley, R. Daniel Beauchamp
Publikováno v:
International journal of radiation oncology, biology, physics. 61(5)
Purpose: Fluorinated pyrimidines have been established as radiosensitizers in the combined modality therapy of esophageal cancer. UFT, an oral combination of a 5-fluorouracil pro-drug (uracil) and a dihydropyrimidine dehydrogenase inhibitor (ftorafur
Autor:
Ken Wyman, Michael B. Atkins, Victor Prieto, Omar Eton, David F. McDermott, Francie Hubbard, Christine Byrnes, Kathleen Sanders, Jeffrey A. Sosman
Publikováno v:
Cancer (0008543X); Apr2006, Vol. 106 Issue 9, p2005-2011, 7p